Oncotype DX for colon cancer

From Aaushi
Jump to navigation Jump to search

Indications

Contraindications

Specimen

  • tissue from colorectal biopsy or surgical specimens

Procedure

Notes

  • introduced in 2010

More general terms

Additional terms

References

  1. Gray RG, Quirke P, Handley K, et al. Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer J Clin Oncol. 2011; 29(32): PMID: https://www.ncbi.nlm.nih.gov/pubmed/22067390
  2. Clark-Langone KM, Sangli C, Krishnakumar J, Watson D. Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay. BMC Cancer. 2010 Dec 23;10:691 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21176237